Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
11
×
clinical trials
11
×
boston blog main
life sciences
national blog main
boston top stories
san francisco blog main
national top stories
san francisco top stories
biotech
fda
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
boulder/denver blog main
boulder/denver top stories
cancer drugs
detroit blog main
detroit top stories
indiana blog main
indiana top stories
loxo oncology
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
blueprint medicines
deals
ipo
sanofi
startups
amgen
black diamond therapeutics
What
cancer
11
×
drug
ipo
medicines
fda
medicine
new
research
targets
biotech
black
cash
clinical
patients
pharmaceutical
proteins
reach
revolution
roundup
ahead
aim
ambien
american
announced
annual
appetite
approval
approved
artificially
asco
attendees
attention
best
bio
blood
blueprint
boost
bread
broader
butter
Language
unset
Current search:
cancer
×
cancer
×
" clinical trials "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@techcrunch.com
6 years ago
Mendel.ai nabs $2 million to match cancer patients with the latest clinical trials